EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC

Clinical trial NCT04139057 · COMPLETED

Trial details

NCT number: NCT04139057
Sponsor: Xinqiao Hospital of Chongqing
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2019-03-01
Primary completion: 2026-01-15
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.